Product Information

AMLODIPINE-OLMESARTAN 5-40 MG is a generic product labeled by Macleods Pharmaceuticals Limited, priced at $0.2934 per EA under NDC 33342019107. Its NADAC has been published 493 times since Jan 18, 2017.

AMLODIPINE-OLMESARTAN 5-40 MG

AMLODIPINE and OLMESARTAN medoxomil
$0.2934per EA

Strength

5; 40 mg/1; mg/1

NDC

33342019107

Classification

Generic

Dosage Form

TABLET, FILM COATED

Route

ORAL

Last Updated

6/17/2026

Approval Type

Generic (ANDA)

FDA Application

ANDA206884

On Market Since

10/27/2016

Pharmacological Classes

Angiotensin 2 Receptor Antagonists
Angiotensin 2 Receptor Blocker
Calcium Channel Antagonists
Calcium Channel Blocker
Cytochrome P450 3A Inhibitors
Dihydropyridine Calcium Channel Blocker
Dihydropyridines

Price Statistics

The NADAC for AMLODIPINE-OLMESARTAN 5-40 MG has been published 493 times since Jan 18, 2017, and over the history we have for it it has declined 71.8%. The table below summarizes its recorded NADAC range and movement.

Current price$0.2934 per EA
All-time high$1.1864 (Apr 12, 2017)
All-time low$0.2762 (Apr 22, 2026)
52-week high$0.3870
52-week low$0.2762
Median price$0.4744
Average price$0.5688
Largest weekly change-45.3% (Nov 18, 2020)
Weeks tracked493
Tracking sinceJan 18, 2017

Price History

1W

0.0%

1M

+3.0%

3M

+4.5%

6M

-5.9%

1Y

-24.2%

3Y

-34.6%

5Y

-38.2%

All

-71.8%

Generic Alternatives

The matcher finds 1 NADAC-published product sharing this drug's active ingredient, strength, and dosage form across 1 manufacturer (up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.

Frequently asked questions

What is the NADAC price of AMLODIPINE-OLMESARTAN 5-40 MG?

The current National Average Drug Acquisition Cost (NADAC) for AMLODIPINE-OLMESARTAN 5-40 MG, manufactured by Macleods Pharmaceuticals Limited, is $0.2934 per EA (NDC 33342019107), effective Jun 24, 2026.

How has the price of AMLODIPINE-OLMESARTAN 5-40 MG changed over time?

Over the history we have for it, the NADAC for AMLODIPINE-OLMESARTAN 5-40 MG has declined 71.8%. It has been tracked across 493 weekly CMS publications since Jan 18, 2017.

What are the highest and lowest recorded NADAC prices for AMLODIPINE-OLMESARTAN 5-40 MG?

Since Jan 18, 2017, the NADAC for AMLODIPINE-OLMESARTAN 5-40 MG has ranged from a low of $0.2762 (Apr 22, 2026) to a high of $1.1864 (Apr 12, 2017), with a median of $0.4744 per EA.

Are there cheaper alternatives to AMLODIPINE-OLMESARTAN 5-40 MG?

1 NADAC-published product shares the same active ingredient, strength, and dosage form as AMLODIPINE-OLMESARTAN 5-40 MG, but none are currently priced below it.

Who manufactures AMLODIPINE-OLMESARTAN 5-40 MG?

AMLODIPINE-OLMESARTAN 5-40 MG (NDC 33342019107) is labeled by Macleods Pharmaceuticals Limited, and CMS classifies it as a generic product.